Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Singer, H. S. Articles by Wong, D. F. Search for Related Content PubMed Citation Articles by Singer, H. S. Articles by Wong, D. F. Neurotransmitters Tourette's PET

Elevated Intrasynaptic Dopamine Release in Tourette’s Syndrome Measured by PET

OBJECTIVE: Dopaminergic abnormalities in frontal-subcortical circuits have been hypothesized as the underlying pathophysiologic mechanism in Tourette’s syndrome. The objective of this study was to test the hypothesis that presynaptic dopamine release from the striatum is abnormal in adults with Tourette’s syndrome. METHOD: Seven adults with Tourette’s syndrome and five age-matched comparison subjects each received two positron emission tomography (PET) scans with high specific activity [¹¹C]raclopride. The first scan followed an intravenous injection of saline; the second followed an intravenous injection of amphetamine. The relative dopamine release was estimated as the percentage difference in binding potential between the postsaline and postamphetamine scans. RESULTS: Binding potential determined after the initial [¹¹C]raclopride scan did not significantly differ between Tourette’s syndrome and comparison subjects. After amphetamine challenge, the mean value of intrasynaptic dopamine in the putamen (as determined by true equilibrium bolus estimation) increased by 21% in the subjects with Tourette’s syndrome and did not change in the comparison subjects; the mean values increased by 16.9% and decreased by 1.8%, respectively, when measured by the constrained method. Dopamine release in the caudate region was not significantly different in the Tourette’s syndrome and comparison subjects. CONCLUSIONS: Greater putamen dopamine release was seen in adults with Tourette’s syndrome than in comparison subjects after a pharmacologic challenge with amphetamine. These results suggest that the underlying pathobiology in Tourette’s syndrome is a phasic dysfunction of dopamine transmission.

This article has been cited by other articles:

				J. Jankovic, C. Kwak, and R. Frankoff Tourette's Syndrome and the Law. J Neuropsychiatry Clin Neurosci, December 1, 2006; 18(1): 86 - 95. [Abstract] [Full Text] [PDF]

				K. A. Frey and R. L. Albin Neuroimaging of Tourette Syndrome J Child Neurol, August 1, 2006; 21(8): 672 - 677. [Abstract] [PDF]

				A. Nevet, G. Morris, G. Saban, N. Fainstein, and H. Bergman Discharge Rate of Substantia Nigra Pars Reticulata Neurons Is Reduced In Non-Parkinsonian Monkeys With Apomorphine-Induced Orofacial Dyskinesia J Neurophysiol, October 1, 2004; 92(4): 1973 - 1981. [Abstract] [Full Text] [PDF]

				R.L. Albin, R.A. Koeppe, N.I. Bohnen, T.E. Nichols, P. Meyer, K. Wernette, S. Minoshima, M.R. Kilbourn, and K.A. Frey Increased ventral striatal monoaminergic innervation in Tourette syndrome Neurology, August 12, 2003; 61(3): 310 - 315. [Abstract] [Full Text] [PDF]

				Minerva BMJ, September 7, 2002; 325(7363): 554 - 554. [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2002 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us